CERITINIB for Neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 35 adverse event reports in the FDA FAERS database where CERITINIB was used for Neoplasm malignant.
Most Reported Side Effects for CERITINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Malignant neoplasm progression | 523 | 18.7% | 196 | 156 |
| Diarrhoea | 452 | 16.2% | 71 | 118 |
| Death | 391 | 14.0% | 390 | 38 |
| Nausea | 381 | 13.6% | 80 | 127 |
| Vomiting | 270 | 9.7% | 63 | 94 |
| Metastases to central nervous system | 203 | 7.3% | 62 | 65 |
| Non-small cell lung cancer | 183 | 6.6% | 83 | 53 |
| Fatigue | 149 | 5.3% | 30 | 48 |
| Decreased appetite | 139 | 5.0% | 32 | 59 |
| Dyspnoea | 137 | 4.9% | 42 | 79 |
| Disease progression | 116 | 4.2% | 24 | 14 |
| Abdominal pain | 108 | 3.9% | 25 | 47 |
| Asthenia | 104 | 3.7% | 26 | 45 |
| Non-small cell lung cancer stage iv | 91 | 3.3% | 48 | 35 |
| Pyrexia | 88 | 3.2% | 22 | 50 |
Other Indications for CERITINIB
Non-small cell lung cancer (1,019)
Product used for unknown indication (537)
Lung neoplasm malignant (394)
Non-small cell lung cancer stage iv (157)
Lung adenocarcinoma (155)
Non-small cell lung cancer metastatic (90)
Anaplastic lymphoma kinase gene mutation (58)
Lung carcinoma cell type unspecified stage 0 (46)
Lung adenocarcinoma stage iv (33)
Lung cancer metastatic (22)
Other Drugs Used for Neoplasm malignant
PALBOCICLIB (1,996)
CAPECITABINE (1,493)
PEMBROLIZUMAB (1,135)
PACLITAXEL (984)
CARBOPLATIN (977)
NIVOLUMAB (947)
OXALIPLATIN (823)
PAZOPANIB (716)
CYCLOPHOSPHAMIDE (685)
FLUOROURACIL (676)